Dana Investment Advisors, Inc.
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1427514
BROOKFIELD, WI
Position in AXSM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,458,578
-$1,604,522 QoQ
Shares Held
26,379
-20.5% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 87.95253800371508.ToString("F0")%
Shared 0.ToString("F0")%
None 12.047461996284923.ToString("F0")%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. AXSM ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
69,234 | $13,822,568 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,397 | $6,487,858 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
This page
|
26,379 | $4,458,578 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
59,756 | $1,944,460 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,197 | $1,673,533 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
43,954 | $1,460,151 | |
| 7 | ZYME |
Zymeworks Inc.
|
56,107 | $1,404,919 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
18,487 | $1,388,188 |
All Filings in AXSM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,458,578 | 26,379 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,063,100 | 33,197 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,082,177 | 33,612 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,512,980 | 24,073 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,319,435 | 11,313 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,387,096 | 16,394 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,579,644 | 17,577 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,587,782 | 19,724 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $1,518,354 | 19,027 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,085,687 | 13,641 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $988,803 | 14,148 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,265,885 | 17,616 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,162,421 | 18,846 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,459,762 | 18,926 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $663,276 | 14,865 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $669,254 | 17,474 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $662,488 | 16,006 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $741,205 | 19,619 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,001,160 | 30,375 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,338,946 | 19,848 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,038,524 | 18,342 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||